Calculating Your Cancer Risk Factors

Understanding your cancer risk is about looking at the big picture. While a PALB2 mutation increases the likelihood of certain cancers, it is not a guarantee that you will develop them. These risks are described as lifetime risks, meaning the probability of a diagnosis between birth and age 80 ^[1].

It is important to remember that these percentages are population averages based on large family studies, not a direct prediction of what will happen to you.

Breast Cancer Risk

The most significant risk associated with a PALB2 mutation is female breast cancer. For women with this mutation, the estimated lifetime risk to age 80 ranges widely based on family history, but averages approximately 53% in family-based studies ^[1]. To put this in perspective, the risk for the general population is about 13% ^[1]. It is important to note that the relative risk—how much higher your risk is compared to someone without the mutation—is highest when you are younger and tends to decrease as you get older ^[1].

For men, the lifetime risk of breast cancer is significantly lower but still higher than the general population. Men with a PALB2 mutation have approximately a 1% lifetime risk of breast cancer ^[1]. Because male breast cancer is extremely rare in the general population (less than 0.1%), this represents a notable increase that warrants awareness.

Ovarian and Pancreatic Cancer Risks

While PALB2 is primarily known for its link to breast cancer, it also increases the risk for two other specific types of cancer:

• Ovarian Cancer: The lifetime risk to age 80 is estimated at 5% ^[1]. While this is lower than the risks associated with BRCA1 or BRCA2, it is higher than the general population risk of about 1.3% ^[2].
• Pancreatic Cancer: Both men and women with a PALB2 mutation face an increased risk of pancreatic cancer, estimated at 2% to 3% by age 80 ^[1]. In the general population, this risk is roughly 1.5%.

Clarifying Common Misconceptions

You may see information online suggesting that PALB2 is linked to a wide variety of other cancers. However, large-scale international studies have carefully examined these claims.

Current evidence shows no established clinically actionable increase based on current evidence for the following:

• Prostate Cancer: Research has found no evidence that PALB2 mutations increase the risk of prostate cancer ^[1].
• Colorectal Cancer: Similarly, there is no evidence of an increased risk for colon or rectal cancers linked specifically to PALB2 ^[1][3].

If these cancers run in your family, they may be due to other genetic factors or shared environmental influences, but they are not currently considered part of the “PALB2 spectrum” ^[4]. You should not ignore a strong family history of prostate or colorectal cancer just because PALB2 isn’t the primary driver.

How Your Family History Affects Your Risk

The percentages above (like the 53% for breast cancer) are averages. Your individual risk may be higher or lower depending on your family history ^[5].

Geneticists use a concept called penetrance, which refers to how likely it is that a person with a specific mutation will actually develop the disease. For PALB2, penetrance can be modified by:

• The Number of Affected Relatives: If several close relatives (like a mother and sister) have had breast cancer, your personal risk may sit at the higher end of the estimated range ^[1].
• Age of Diagnosis: Having a relative diagnosed at a very young age (e.g., before age 40) may also suggest a higher individual risk ^[1].
• Other Genetic Factors: You likely have other, smaller genetic variations that can either slightly increase or decrease the “workload” of your PALB2 gene ^[6].

Because your family history acts as a “modifier,” your doctor or genetic counselor will use your unique family tree to tailor these general statistics to your specific life situation ^[5].